Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Clin Nutr ; 31(3): 396-404, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22122868

RESUMO

BACKGROUND & AIMS: Omega-3 fatty acids (ω-3FA) attenuate postoperative immunosuppression vis-à-vis infection. Since immune-surveillance targets metastasizing cancer cells, we assessed the effect of ω-3FA consumption on 1) early post-operative Natural Killer cell (NK) cytotoxicity and metastases and 2) long-term recurrence-free survival, in two rodent models of surgery-promoted metastases. METHODS: C57BL/6J mice were fed standard, ω-3FA-enriched, or ω-6FA-enriched chow, beginning one week before subcutaneous footpad implantation of syngeneic melanoma cells. When tumors reached the volume of 110 µl, the tumor-bearing footpad was amputated, and long-term recurrence-free survival was assessed. Also, F344 rats were fed ω-3FA or ω-6FA for a month before undergoing or not undergoing laparotomy, and were intravenously inoculated with radio-labeled syngeneic adenocarcinoma cells. Marginating-pulmonary (MP)-leukocytes were harvested, and lung tumor retention (LTR) of metastases was assessed. RESULTS: ω-3FA consumption did not affect the growth of footpad tumors, but significantly enhanced post-amputation recurrence-free survival in mice. Surgery had a deleterious effect on NK cell activity and LTR whereas ω-3FA had large beneficial effects in non-operated rats and an even greater impact in operated rats. CONCLUSIONS: ω-3FA feeding attenuates or even overcomes postoperative NK cell suppression, increases resistance to experimental and spontaneous metastasis, and enhances recurrence-free survival following excision of metastasizing primary tumors. These findings warrant clinical studies of ω-3FA-based nutrition in patients undergoing resection of a primary tumor.


Assuntos
Ácidos Graxos Ômega-3/uso terapêutico , Óleos de Peixe/uso terapêutico , Vigilância Imunológica , Inoculação de Neoplasia , Neoplasias Experimentais/imunologia , Neoplasias Experimentais/prevenção & controle , Adenocarcinoma/dietoterapia , Adenocarcinoma/imunologia , Adenocarcinoma/secundário , Adenocarcinoma/cirurgia , Animais , Terapia Combinada , Citotoxicidade Imunológica , Feminino , Células Matadoras Naturais/imunologia , Leucócitos/imunologia , Neoplasias Pulmonares/imunologia , Neoplasias Pulmonares/prevenção & controle , Neoplasias Pulmonares/secundário , Masculino , Melanoma Experimental/imunologia , Melanoma Experimental/prevenção & controle , Melanoma Experimental/secundário , Melanoma Experimental/cirurgia , Camundongos , Camundongos Endogâmicos C57BL , Neoplasias Experimentais/dietoterapia , Neoplasias Experimentais/cirurgia , Distribuição Aleatória , Ratos , Ratos Endogâmicos F344 , Prevenção Secundária , Análise de Sobrevida
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA